XML 27 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Shareholders' Equity
3 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Shareholders' equity

NOTE 7 – SHAREHOLDERS’ EQUITY

 

Common Stock

 

On June 2, 2014, the Company issued 10,000,000 shares of its common stock to Chisholm II in exchange for oil and natural gas assets recorded at $1,898,947.

 

As discussed above, the Company completed a reverse merger with Dala, with Dala being the acquirer for financial reporting purposes. At the date of the Merger, Westcott had 2,500,000 shares of common stock outstanding, which are now outstanding for the merged Company. The total amount of shares issued and outstanding post-Merger, as of June 30, 2014 was 12,500,000 shares of common stock.

 

As discussed above, in November 2014, a shareholder converted 17 shares of Series A 6% convertible preferred shares of common stock into 24,286 common shares. As of December 31, 2014 there are a total of 12,524,286 common shares outstanding.

 

Stock-Based Compensation

 

On June 2, 2014, the Company granted options to acquire common shares to its Chief Executive Officer and two directors, totaling 600,000 options. The options have an exercise price of $0.70 per share for terms of six years. Of the total stock options, 400,000 vest equally over the next four years and 200,000 vest equally over the next two years. The total fair value of these options at the date of grant was estimated to be $400,087, and was determined using the Black-Scholes option pricing model with an expected lives of 4.25 (four-year vesting) and 3.75 years (two-year vesting), a risk-free interest rate of 1.92%, a dividend yield of 0% and expected volatility of 195%. The expected terms were determined using the simplified method. During the period from Inception to December 31, 2014, the Company recorded approximately $33,261 of stock-based compensation expense.

 

The following is a summary of the status of all of the Company’s stock options as of December 31, 2014 and changes during the period ended on that date:

             
 

Number

of Options

 

Weighted-

Average

Exercise Price

 

Weighted-

Average

Remaining

Contractual Life

(Years)

Outstanding at September 30, 2014 600,000   $ 0.70   5.68
Granted -     -   -
Exercised -     -   -
Cancelled -     -   -
Outstanding at December 31, 2014 600,000   $ 0.70   5.43
Exercisable at December 31, 2014 -   $ -   -

 

As of December 31, 2014, the intrinsic value of outstanding stock options was $384,000.